Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169369611> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2169369611 endingPage "65" @default.
- W2169369611 startingPage "61" @default.
- W2169369611 abstract "Rationale and aim: Upper airway disorders, like allergic and non-allergic rhinitis, are common nasal conditions affecting millions of individuals worldwide. The prevalence of allergic rhinitis (AR), in particular, has been increasing in the last decades. The pervasiveness of this disorder therefore imposes a large burden both on individual patients and the society. A wide range of drugs exists for symptomatic treatment of rhinitis, such as corticosteroids, decongestants, and an- tihistamines, but standard therapies are often associated with several side effects. A new class of medical devices, based on bio-mechanically innovative triggers, has been proven to have a good clinical effectiveness with lower adverse reac- tions, particularly over prolonged administration periods. The present study aims at evaluating the economic impact of rhinitis, with respect to direct and indirect costs, and analys- ing the use of the medical device Narivent ® compared to standard therapies to manage the symptoms of this illness. Methods: Via a Monte Carlo simulation study, data on disease prevalence, drug prescription and cost of both the specific therapeutic approach and the adverse events treatment will be combined to provide an estimate of the overall cost of the pharmacotherapy as compared with Narivent ® . Results: Lowering the impact of adverse reactions related to standard therapy through the use of novel therapeutic ap- proaches like Narivent ® , might reduce the overall burden of rhinitis by about 5 billion per year. Conclusion: The use of the medical device Narivent ® , as an alternative approach to manage symptoms associated with rhinitis, may contribute to bring down its costs by about 3.5% yearly as compared to the standard therapy." @default.
- W2169369611 created "2016-06-24" @default.
- W2169369611 creator A5059838584 @default.
- W2169369611 date "2012-09-20" @default.
- W2169369611 modified "2023-09-24" @default.
- W2169369611 title "Economic Impact of Treatments for Controlling Symptoms Associated with Rhinitis: an Evaluation of Narivent® vs Standard Therapy" @default.
- W2169369611 cites W1586108659 @default.
- W2169369611 cites W1657102408 @default.
- W2169369611 cites W1658282642 @default.
- W2169369611 cites W1762047569 @default.
- W2169369611 cites W1788768743 @default.
- W2169369611 cites W1996618455 @default.
- W2169369611 cites W2004225647 @default.
- W2169369611 cites W2011357422 @default.
- W2169369611 cites W2031826255 @default.
- W2169369611 cites W2038060545 @default.
- W2169369611 cites W2043732926 @default.
- W2169369611 cites W2053902652 @default.
- W2169369611 cites W2079229667 @default.
- W2169369611 cites W2096210343 @default.
- W2169369611 cites W2106998750 @default.
- W2169369611 cites W2111692694 @default.
- W2169369611 cites W2113429067 @default.
- W2169369611 cites W2126109195 @default.
- W2169369611 cites W2137512787 @default.
- W2169369611 cites W2163304234 @default.
- W2169369611 cites W2164132449 @default.
- W2169369611 cites W2407435587 @default.
- W2169369611 cites W2417131371 @default.
- W2169369611 cites W3024164138 @default.
- W2169369611 cites W3192241548 @default.
- W2169369611 cites W2300672056 @default.
- W2169369611 doi "https://doi.org/10.2174/1875181401204010061" @default.
- W2169369611 hasPublicationYear "2012" @default.
- W2169369611 type Work @default.
- W2169369611 sameAs 2169369611 @default.
- W2169369611 citedByCount "0" @default.
- W2169369611 crossrefType "journal-article" @default.
- W2169369611 hasAuthorship W2169369611A5059838584 @default.
- W2169369611 hasBestOaLocation W21693696111 @default.
- W2169369611 hasConcept C177713679 @default.
- W2169369611 hasConcept C71924100 @default.
- W2169369611 hasConceptScore W2169369611C177713679 @default.
- W2169369611 hasConceptScore W2169369611C71924100 @default.
- W2169369611 hasIssue "1" @default.
- W2169369611 hasLocation W21693696111 @default.
- W2169369611 hasOpenAccess W2169369611 @default.
- W2169369611 hasPrimaryLocation W21693696111 @default.
- W2169369611 hasRelatedWork W1506200166 @default.
- W2169369611 hasRelatedWork W1995515455 @default.
- W2169369611 hasRelatedWork W2039318446 @default.
- W2169369611 hasRelatedWork W2080531066 @default.
- W2169369611 hasRelatedWork W2748952813 @default.
- W2169369611 hasRelatedWork W2899084033 @default.
- W2169369611 hasRelatedWork W3031052312 @default.
- W2169369611 hasRelatedWork W3032375762 @default.
- W2169369611 hasRelatedWork W3108674512 @default.
- W2169369611 hasRelatedWork W4252371801 @default.
- W2169369611 hasVolume "4" @default.
- W2169369611 isParatext "false" @default.
- W2169369611 isRetracted "false" @default.
- W2169369611 magId "2169369611" @default.
- W2169369611 workType "article" @default.